Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1982 3
1983 2
1984 7
1985 2
1987 2
1988 1
1989 8
1990 8
1991 7
1992 10
1993 6
1994 5
1995 5
1996 8
1997 2
1998 4
1999 3
2000 3
2001 6
2002 7
2003 4
2004 3
2005 4
2006 4
2007 4
2008 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.
Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C, Collette L; EORTC Genito-Urinary Cancer Group. Sternberg CN, et al. Among authors: schornagel jh. Eur J Cancer. 2006 Jan;42(1):50-4. doi: 10.1016/j.ejca.2005.08.032. Epub 2005 Dec 5. Eur J Cancer. 2006. PMID: 16330205 Clinical Trial.
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
Sternberg CN, de Mulder PH, Schornagel JH, Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van Groeningen CJ, de Balincourt C, Collette L; European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. Sternberg CN, et al. Among authors: schornagel jh. J Clin Oncol. 2001 May 15;19(10):2638-46. doi: 10.1200/JCO.2001.19.10.2638. J Clin Oncol. 2001. PMID: 11352955 Clinical Trial.
Antimetabolites.
Schornagel JH. Schornagel JH. Curr Opin Oncol. 1989 Dec;1(2):179-85. Curr Opin Oncol. 1989. PMID: 2489957 Review. No abstract available.
Clinical pharmacokinetics of anti-metabolites.
Peters GJ, Schornagel JH, Milano GA. Peters GJ, et al. Among authors: schornagel jh. Cancer Surv. 1993;17:123-56. Cancer Surv. 1993. PMID: 8137339 Review.
Hypersensitivity reactions to etoposide.
Hoetelmans RM, Schornagel JH, ten Bokkel Huinink WW, Beijnen JH. Hoetelmans RM, et al. Among authors: schornagel jh. Ann Pharmacother. 1996 Apr;30(4):367-71. doi: 10.1177/106002809603000409. Ann Pharmacother. 1996. PMID: 8729891 Review.
The clinical pharmacology of methotrexate.
Schornagel JH, McVie JG. Schornagel JH, et al. Cancer Treat Rev. 1983 Mar;10(1):53-75. doi: 10.1016/s0305-7372(83)80032-2. Cancer Treat Rev. 1983. PMID: 6342775 Review. No abstract available.
Major and minor salivary glands tumours.
Licitra L, Grandi C, Prott FJ, Schornagel JH, Bruzzi P, Molinari R. Licitra L, et al. Among authors: schornagel jh. Crit Rev Oncol Hematol. 2003 Feb;45(2):215-25. doi: 10.1016/s1040-8428(02)00005-7. Crit Rev Oncol Hematol. 2003. PMID: 12604131 Review.
Is there a role for thymidine in cancer chemotherapy?
Schornagel JH, Leyva A, Pinedo HM. Schornagel JH, et al. Cancer Treat Rev. 1982 Dec;9(4):331-52. doi: 10.1016/s0305-7372(82)80044-3. Cancer Treat Rev. 1982. PMID: 6762925 Review. No abstract available.
120 results